The dosing of these two patients demonstrates Cellares’ GMP manufacturing and supply chain capabilities with their automated platform.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results